Fight or Flight?
As the old orthodoxy shatters, pharma must stand firm or leave the field.
From Promise to Payoff
Our sixth annual pipeline report details 44 drugs that industry will be talking about in 2010.
End the Drug Drought
The fight against cancer may be the litmus test for how regulation and private investment work together to address the disease burden.
European Pharma Finally Becomes a Health Matter
December 01
The Evolving Drug Safety Landscape: Implications for Pharma
01 December
FDA Warning Letters Target Illegal Online Pharmacies
Feds targeted 136 Web sites offering foreign or unapproved drugs as part of International Internet Week of Action. But does the FDA campaign ignore a larger crisis endangering consumers?
Life Technologies improves e-commerce infrastructure with the help of Infosys
Rising to the Challenge in R&D
Allosteric modulators are an emerging class of orally available small molecule drugs that may have multiple advantages compared to traditional drugs.
standard terms and conditions
Pfizer Quick on the Draw with R&D Location Plans
Following through with its promise to waste no time in merging Wyeth and Pfizer, the pharma giant announced restructuring plans for its global research network.
GSK Donates 50 Million H1N1 Doses To WHO
Developing countries will receive the scarce vaccine for free, as GSK remains confident it will fulfill contractual vaccine obligations around the world.
J&J Cuts Staff in Major Restructuring Move
Johnson & Johnson announced a massive restructuring plan on Tuesday in an effort to save $1.4 billion to $1.7 billion by 2011. The human cost: 7 percent of its workforce.
Glaxo Vies for a Second Act in HIV
A novel joint venture between Glaxo and Pfizer is big on promise. But the combined portfolio and pipeline of HIV drugs? Not so much.
Novo Nordisk Reports 30% Increased Operating Profit
02 November
The Incredible Shrinking Margin?
Emerging country markets are the new black in great expectations for pharma.
The Healthcare Thicket
Despite its success as a proponent of reform, the drug industry, whose main offering is a product easily siloed against other health services, remains vulnerable.
Sanofi Warned for Misleading Tent Card
Sure, prescription information for Sanofi-Aventis's Uroxatral appears on the back of the tent card, but how can consumer?s see it if it's mounted to a pharmacy wall?
GAO Accuses FDA of Tardy Trial Data
The US oversight arm scripted a hefty report complaining that FDA is not moving fast enough when it comes to screening clinical trials data for drugs green lit through its expedited approval program.
Pfizer Profits Spike as Wyeth Deal is Finalized
The third quarter reports are in, and Pfizer's profits are up but sales are down. The company is compensating for looming patent expirations with layoffs and restructuring; is it enough to boost sales?
UK's NICE Rejects GSK Breast Cancer Treatment
21 October
What's the best managed pharma company? Find out in the Industry Audit and Company of the Year Podcast
Industry Audit and Company of The year.
Switzerland's Medicines for Malaria Receives Gates Foundation Award
19 October
Emerging Pharma Leadership Awards - Michelle Dipp
Professional Scientific StaffingSM Solutions - Lancaster Whitepaper
Emerging Pharma Leadership Awards - Elizabeth Mutisya
Emerging Pharma Leadership Awards - Luca Santarelli
Emerging Pharma Leadership Awards - Kathryn Metcalfe
PharmRep 2010 Sworn Statement
PharmRep 2010 sworn statement
Emerging Pharma Leadership Awards - Jennifer Smith
